Carrier screening for recessive disorders (Q92382672)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31142809 AND SRC:MED&resulttype=core&format=json

29 April 2020

review article

1 reference

title

Carrier screening for recessive disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31142809 AND SRC:MED&resulttype=core&format=json

29 April 2020

author

Stilianos Antonarakis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31142809 AND SRC:MED&resulttype=core&format=json

29 April 2020

publication date

1 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31142809 AND SRC:MED&resulttype=core&format=json

29 April 2020

published in

Nature Reviews Genetics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31142809 AND SRC:MED&resulttype=core&format=json

29 April 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31142809 AND SRC:MED&resulttype=core&format=json

29 April 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31142809 AND SRC:MED&resulttype=core&format=json

29 April 2020

page(s)

549-561

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31142809 AND SRC:MED&resulttype=core&format=json

Clinical genomic database

29 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

The aims of expanded universal carrier screening: Autonomy, prevention, and responsible parenthood

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

The evolving landscape of expanded carrier screening: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Global burden of genetic disease and the role of genetic screening

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Protection afforded by sickle-cell trait against subtertian malareal infection

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Clinical genomics can facilitate countrywide estimation of autosomal recessive disease burden

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Diagnostic Exome Sequencing to Elucidate the Genetic Basis of Likely Recessive Disorders in Consanguineous Families

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Genetics of Early Onset Cognitive Impairment

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Quantifying the contribution of recessive coding variation to developmental disorders

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

The mutational constraint spectrum quantified from variation in 141,456 humans

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Analysis of protein-coding genetic variation in 60,706 humans

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Deep sequencing of 10,000 human genomes

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

The UK's 100,000 Genomes Project: manifesting policymakers' expectations

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

De novo mutations in regulatory elements in neurodevelopmental disorders.

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

A map of human genome variation from population-scale sequencing

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Human genome sequencing in health and disease

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

An empirical estimate of carrier frequencies for 400 causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Effect of inbreeding on intellectual disability revisited by Trio sequencing

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Consanguinity in the contemporary world

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Consanguineous marriages, pearls and perils: Geneva International Consanguinity Workshop Report

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Consanguinity and its relevance to clinical genetics.

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

ENDOGAMY, CONSANGUINITY AND THE HEALTH IMPLICATIONS OF CHANGING MARITAL CHOICES IN THE UK PAKISTANI COMMUNITY.

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Runs of homozygosity: windows into population history and trait architecture.

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Committee Opinion No. 691: Carrier Screening for Genetic Conditions

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Genetic testing in Israel: an overview

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

https://api.crossref.org/works/10.1038/S41576-019-0134-2

1 reference

7 January 2021

Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

ClinVar: improving access to variant interpretations and supporting evidence

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Reclassification of and variants of uncertain significance: a multifactorial analysis of multicentre prospective cohort

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Next generation disparities in human genomics: concerns and remedies

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Beyond Mendel: an evolving view of human genetic disease transmission

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Visual impairment and progressive phthisis bulbi caused by recessive pathogenic variant in MARK3

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Hb S-β-thalassemia: molecular, hematological and clinical comparisons.

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Functional Assays Are Essential for Interpretation of Missense Variants Associated with Variable Expressivity

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

A systematic analysis of online marketing materials used by providers of expanded carrier screening

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Expanded carrier screening for monogenic disorders: where are we now?

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Ethical and policy issues in genetic testing and screening of children

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome Sequencing

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

The inherited diseases of hemoglobin are an emerging global health burden

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Prevention of thalassaemia in Cyprus

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Global epidemiology of hemoglobin disorders

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Results of programmes for antenatal detection of thalassemia in reducing the incidence of the disorder

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Tay-Sachs Disease: Generalized Absence of a Beta-D- N -Acetylhexosaminidase Component

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

It's "back to school" for genetic screening

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Identification of the cystic fibrosis gene: genetic analysis

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Committee Opinion No. 486: Update on Carrier Screening for Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Practice patterns of obstetrician-gynecologists regarding preconception and prenatal screening for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research.

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Association between carrier screening and incidence of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Influence of five years of antenatal screening on the paediatric cystic fibrosis population in one region

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Newborn screening showing decreasing incidence of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

A CFTR potentiator in patients with cystic fibrosis and the G551D mutation

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Carrier screening for cystic fibrosis in the new era of medications that restore CFTR function

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests.

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Responsible implementation of expanded carrier screening

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Committee Opinion No. 690 Summary

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

ACMG position statement on prenatal/preconception expanded carrier screening

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal

1 reference

https://api.crossref.org/works/10.1038/S41576-019-0134-2

7 January 2021

10.1038/S41576-019-0134-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31142809 AND SRC:MED&resulttype=core&format=json

29 April 2020

1 reference